These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 34282151)

  • 61. Acyltransferase skinny hedgehog regulates TGFβ-dependent fibroblast activation in SSc.
    Liang R; Kagwiria R; Zehender A; Dees C; Bergmann C; Ramming A; Krasowska D; Michalska-Jakubus M; Kreuter A; Kraner ME; Schett G; Distler JHW
    Ann Rheum Dis; 2019 Sep; 78(9):1269-1273. PubMed ID: 31177096
    [TBL] [Abstract][Full Text] [Related]  

  • 62. An Autotaxin/Lysophosphatidic Acid/Interleukin-6 Amplification Loop Drives Scleroderma Fibrosis.
    Castelino FV; Bain G; Pace VA; Black KE; George L; Probst CK; Goulet L; Lafyatis R; Tager AM
    Arthritis Rheumatol; 2016 Dec; 68(12):2964-2974. PubMed ID: 27390295
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Interfacial Adipose Tissue in Systemic Sclerosis.
    Kruglikov IL
    Curr Rheumatol Rep; 2017 Jan; 19(1):4. PubMed ID: 28138823
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Inhibition of casein kinase II reduces TGFβ induced fibroblast activation and ameliorates experimental fibrosis.
    Zhang Y; Dees C; Beyer C; Lin NY; Distler A; Zerr P; Palumbo K; Susok L; Kreuter A; Distler O; Schett G; Distler JH
    Ann Rheum Dis; 2015 May; 74(5):936-43. PubMed ID: 24431397
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Systems-based identification of the Hippo pathway for promoting fibrotic mesenchymal differentiation in systemic sclerosis.
    Ma F; Tsou PS; Gharaee-Kermani M; Plazyo O; Xing X; Kirma J; Wasikowski R; Hile GA; Harms PW; Jiang Y; Xing E; Nakamura M; Ochocki D; Brodie WD; Pillai S; Maverakis E; Pellegrini M; Modlin RL; Varga J; Tsoi LC; Lafyatis R; Kahlenberg JM; Billi AC; Khanna D; Gudjonsson JE
    Nat Commun; 2024 Jan; 15(1):210. PubMed ID: 38172207
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Suppressive Regulation by MFG-E8 of Latent Transforming Growth Factor β-Induced Fibrosis via Binding to αv Integrin: Significance in the Pathogenesis of Fibrosis in Systemic Sclerosis.
    Fujiwara C; Uehara A; Sekiguchi A; Uchiyama A; Yamazaki S; Ogino S; Yokoyama Y; Torii R; Hosoi M; Suto C; Tsunekawa K; Murakami M; Ishikawa O; Motegi SI
    Arthritis Rheumatol; 2019 Feb; 71(2):302-314. PubMed ID: 30175895
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Scleroderma fibroblasts suppress angiogenesis via TGF-β/caveolin-1 dependent secretion of pigment epithelium-derived factor.
    Liakouli V; Elies J; El-Sherbiny YM; Scarcia M; Grant G; Abignano G; Derrett-Smith EC; Esteves F; Cipriani P; Emery P; Denton CP; Giacomelli R; Mavria G; Del Galdo F
    Ann Rheum Dis; 2018 Mar; 77(3):431-440. PubMed ID: 29259049
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Integrin activating molecule-talin1 promotes skin fibrosis in systemic sclerosis.
    Xu D; Yuan X; Li Z; Mu R
    Front Immunol; 2024; 15():1400819. PubMed ID: 38863696
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Heat shock protein 90 (Hsp90) inhibition targets canonical TGF-β signalling to prevent fibrosis.
    Tomcik M; Zerr P; Pitkowski J; Palumbo-Zerr K; Avouac J; Distler O; Becvar R; Senolt L; Schett G; Distler JH
    Ann Rheum Dis; 2014 Jun; 73(6):1215-22. PubMed ID: 23661493
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The fibrotic phenotype of systemic sclerosis fibroblasts varies with disease duration and severity of skin involvement: reconstitution of skin fibrosis development using a tissue engineering approach.
    Corriveau MP; Boufaied I; Lessard J; Chabaud S; Senécal JL; Grodzicky T; Chartier S; Raymond Y; Moulin VJ
    J Pathol; 2009 Mar; 217(4):534-42. PubMed ID: 19086038
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Reduced SPAG17 Expression in Systemic Sclerosis Triggers Myofibroblast Transition and Drives Fibrosis.
    Sapao P; Roberson EDO; Shi B; Assassi S; Skaug B; Lee F; Naba A; Perez White BE; Córdova-Fletes C; Tsou PS; Sawalha AH; Gudjonsson JE; Ma F; Verma P; Bhattacharyya D; Carns M; Strauss JF; Sicard D; Tschumperlin DJ; Champer MI; Campagnola PJ; Teves ME; Varga J
    J Invest Dermatol; 2023 Feb; 143(2):284-293. PubMed ID: 36116512
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Growth differentiation factor 15, a marker of lung involvement in systemic sclerosis, is involved in fibrosis development but is not indispensable for fibrosis development.
    Lambrecht S; Smith V; De Wilde K; Coudenys J; Decuman S; Deforce D; De Keyser F; Elewaut D
    Arthritis Rheumatol; 2014 Feb; 66(2):418-27. PubMed ID: 24504814
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Parvovirus B19 activates in vitro normal human dermal fibroblasts: a possible implication in skin fibrosis and systemic sclerosis.
    Arvia R; Margheri F; Stincarelli MA; Laurenzana A; Fibbi G; Gallinella G; Ferri C; Del Rosso M; Zakrzewska K
    Rheumatology (Oxford); 2020 Nov; 59(11):3526-3532. PubMed ID: 32556240
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Evolving insights into the cellular and molecular pathogenesis of fibrosis in systemic sclerosis.
    Korman B
    Transl Res; 2019 Jul; 209():77-89. PubMed ID: 30876809
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Role of apoptosis and transforming growth factor beta1 in fibroblast selection and activation in systemic sclerosis.
    Jelaska A; Korn JH
    Arthritis Rheum; 2000 Oct; 43(10):2230-9. PubMed ID: 11037882
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Large-Scale Characterization of Systemic Sclerosis Serum Protein Profile: Comparison to Peripheral Blood Cell Transcriptome and Correlations With Skin/Lung Fibrosis.
    Bellocchi C; Ying J; Goldmuntz EA; Keyes-Elstein L; Varga J; Hinchcliff ME; Lyons MA; McSweeney P; Furst DE; Nash R; Crofford LJ; Welch B; Goldin JG; Pinckney A; Mayes MD; Sullivan KM; Assassi S
    Arthritis Rheumatol; 2021 Apr; 73(4):660-670. PubMed ID: 33131208
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.
    Kawaguchi Y; Takagi K; Hara M; Fukasawa C; Sugiura T; Nishimagi E; Harigai M; Kamatani N
    Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619
    [TBL] [Abstract][Full Text] [Related]  

  • 78. TLR4-dependent fibroblast activation drives persistent organ fibrosis in skin and lung.
    Bhattacharyya S; Wang W; Qin W; Cheng K; Coulup S; Chavez S; Jiang S; Raparia K; De Almeida LMV; Stehlik C; Tamaki Z; Yin H; Varga J
    JCI Insight; 2018 Jul; 3(13):. PubMed ID: 29997297
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Myofibroblasts and hyalinized collagen as markers of skin disease in systemic sclerosis.
    Kissin EY; Merkel PA; Lafyatis R
    Arthritis Rheum; 2006 Nov; 54(11):3655-60. PubMed ID: 17075814
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Simultaneous inhibition of c-Abl and Src kinases abrogates the exaggerated expression of profibrotic genes in cultured systemic sclerosis dermal fibroblasts.
    Piera-Velazquez S; Jimenez SA
    Clin Exp Rheumatol; 2018; 36 Suppl 113(4):36-44. PubMed ID: 30277861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.